Pathophysiology and Clinical Impact of Red Blood Cell Sickling in Sickle Cell Disease

Molecular Basis of Sickle Cell Disease

• The disease is caused by a single‑base substitution (C→A) at codon 6 of the β‑globin gene, converting a hydrophilic glutamic acid to a hydrophobic valine and producing hemoglobin S (α₂βˢ₂) instead of normal adult hemoglobin A (α₂β₂). 1

Polymerization Mechanism

• Under deoxygenated (T‑state) conditions, hemoglobin S polymerizes, and the resulting elongated polymers precipitate, physically distorting the red‑blood‑cell membrane and creating the characteristic sickle or crescent shape. 2
• Oxygen‑bound (R‑state) hemoglobin S inhibits polymerization; therefore, sickling is intermittent and is triggered when oxygen tension falls. 1

Clinical Consequences of Sickling

• Hemolysis: The fragile, misshapen cells undergo premature destruction, leading to chronic anemia with markedly reduced hemoglobin concentrations typical of severe disease. 1
• Vaso‑occlusion: Sickled cells obstruct small vessels, producing tissue ischemia that manifests as acute painful crises and progressive organ damage. 2

Genotype‑Phenotype Correlation

• Genotypes HbSS (homozygous), HbSβ⁰‑thalassemia, and HbSD are associated with severe disease, early painful crises, and pronounced anemia. 1
• Genotypes HbSC and HbSβ⁺‑thalassemia generally result in milder disease, although considerable variability can occur within each group. 2